BRR OpCo’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.69M | Buy |
38,545
+35
| +0.1% | +$1.7K | 0.21% | 70 |
|
|
2022
Q2 | $2.02M | Sell |
38,510
-92
| -0.2% | -$4.69K | 0.24% | 49 |
|
|
2022
Q1 | $2M | Buy |
38,602
+4,545
| +13% | +$236K | 0.21% | 60 |
|
|
2021
Q4 | $2.01M | Sell |
34,057
-6,359
| -16% | -$315K | 0.22% | 59 |
|
|
2021
Q3 | $1.74M | Buy |
40,416
+507
| +1% | +$22.5K | 0.2% | 69 |
|
|
2021
Q2 | $1.56M | Sell |
39,909
-491
| -1% | -$19.1K | 0.17% | 75 |
|
|
2021
Q1 | $1.46M | Sell |
40,400
-1,885
| -4% | -$66.9K | 0.18% | 75 |
|
|
2020
Q4 | $1.56M | Buy |
42,285
+388
| +0.9% | +$14.2K | 0.23% | 59 |
|
|
2020
Q3 | $1.46M | Sell |
41,897
-1,534
| -4% | -$53.8K | 0.24% | 49 |
|
|
2020
Q2 | $1.35M | Sell |
43,431
-1,236
| -3% | -$42K | 0.23% | 47 |
|
|
2020
Q1 | $1.38M | Buy |
44,667
+1,833
| +4% | +$62.5K | 0.26% | 40 |
|
|
2019
Q4 | $1.59M | Sell |
42,834
-2,301
| -5% | -$82K | 0.23% | 42 |
|
|
2019
Q3 | $1.54M | Sell |
45,135
-125
| -0.3% | -$4.54K | 0.25% | 40 |
|
|
2019
Q2 | $1.86M | Sell |
45,260
-22,976
| -34% | -$912K | 0.3% | 32 |
|
|
2019
Q1 | $2.75M | Buy |
68,236
+26,250
| +63% | +$1.05M | 0.47% | 20 |
|
|
2018
Q4 | $1.74M | Sell |
41,986
-1,051
| -2% | -$43.6K | 0.36% | 27 |
|
|
2018
Q3 | $1.8M | Buy |
43,037
+63
| +0.1% | +$2.42K | 0.35% | 24 |
|
|
2018
Q2 | $1.48M | Sell |
42,974
-86
| -0.2% | -$2.94K | 0.41% | 25 |
|
|
2018
Q1 | $1.45M | Sell |
43,060
-1,817
| -4% | -$62.5K | 0.4% | 25 |
|
|
2017
Q4 | $1.54M | Sell |
44,877
-5,888
| -12% | -$201K | 0.42% | 24 |
|
|
2017
Q3 | $1.72M | Buy |
50,765
+1,458
| +3% | +$46.9K | 0.52% | 24 |
|
|
2017
Q2 | $1.57M | Sell |
49,307
-2,015
| -4% | -$63.5K | 0.51% | 24 |
|
|
2017
Q1 | $1.67M | Buy |
51,322
+1,319
| +3% | +$41.6K | 0.55% | 22 |
|
|
2016
Q4 | $1.54M | Sell |
50,003
-25,732
| -34% | -$786K | 0.5% | 24 |
|
|
2016
Q3 | $2.43M | Sell |
75,735
-926
| -1% | -$31K | 0.8% | 18 |
|
|
2016
Q2 | $2.56M | Sell |
76,661
-1,623
| -2% | -$51.8K | 0.86% | 16 |
|
|
2016
Q1 | $2.2M | Sell |
78,284
-1,173
| -1% | -$33.5K | 0.78% | 19 |
|
|
2015
Q4 | $2.43M | Sell |
79,457
-896
| -1% | -$28.2K | 0.9% | 21 |
|
|
2015
Q3 | $2.4M | Buy |
80,353
+534
| +0.7% | +$17.1K | 1.03% | 18 |
|
|
2015
Q2 | $2.54M | Buy |
79,819
+2,704
| +4% | +$88.1K | 1.04% | 19 |
|
|
2015
Q1 | $2.54M | Sell |
77,115
-597
| -0.8% | -$19K | 1.04% | 17 |
|
|
2014
Q4 | $2.3M | Buy |
77,712
+371
| +0.5% | +$10.6K | 0.92% | 17 |
|
|
2014
Q3 | $2.17M | Sell |
77,341
-2,713
| -3% | -$76.1K | 0.89% | 18 |
|
|
2014
Q2 | $2.25M | Buy |
80,054
+22,813
| +40% | +$650K | 0.94% | 18 |
|
|
2014
Q1 | $1.74M | Buy |
57,241
+259
| +0.5% | +$7.72K | 0.76% | 23 |
|
|
2013
Q4 | $1.66M | Sell |
56,982
-2,147
| -4% | -$62.5K | 0.72% | 24 |
|
|
2013
Q3 | $1.61M | Buy |
59,129
+1,191
| +2% | +$32.4K | 0.76% | 22 |
|
|
2013
Q2 | $1.54M | Buy |
+57,938
| New | +$1.6M | 0.74% | 22 |
|
Other funds holding PFE
BRR OpCo's PFE Position: Q3 2022 in Review
BRR OpCo increased its Pfizer (PFE) stake by 0.09% in Q3 2022, buying an estimated $1.7K and bringing the position to 38,545 shares worth $1.69M. The position accounts for 0.21% of the portfolio, ranked #70.
BRR OpCo first reported a position in PFE in Q2 2013 and has held it in 38 quarters since. The position peaked at $2.75M in Q1 2019. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- BRR OpCo held 38,545 shares of Pfizer worth $1.69M as of Q3 2022.
- BRR OpCo bought 35 Pfizer shares in Q3 2022, an estimated $1.7K.
- Pfizer made up 0.21% of BRR OpCo's portfolio in Q3 2022, its #70 holding.
- BRR OpCo first reported a position in Pfizer in Q2 2013 and has held it in 38 quarters since.
- BRR OpCo's Pfizer position peaked at $2.75M in Q1 2019.
- 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on BRR OpCo's 13F filing for Q3 2022, filed 8 Nov 2022.